• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

AAO 2019 Retina Street Team: Key takeaways

Article

Judy E. Kim, MD; David M. Brown, MD; and Charlie C. Wykoff, MD,PhD, share their take on key highlights - what’s in the pharmaceutical pipelines, upcoming and ongoing clinical trials, and the latest update in gene therapy - from the 2019 meeting of the American Academy of Ophthalmology.

Judy E. Kim, MD; David M. Brown, MD; and Charles C. Wykoff, MD,PhD, share their take on key highlights - what’s in the pharmaceutical pipelines, upcoming and ongoing clinical trials, and the latest update in gene therapy - from the 2019 meeting of the American Academy of Ophthalmology.

Read and watch more highlights from the AAO 2019 Retina Street Team. 

Related Videos
© 2024 MJH Life Sciences

All rights reserved.